# Detection of COVID-19 Subjects Using DiaNose Exhalation Test

> **NCT04476927** · NA · UNKNOWN · sponsor: **Nanose Medical Ltd.** · enrollment: 300 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** DiaNose

## Key facts

- **NCT ID:** NCT04476927
- **Lead sponsor:** Nanose Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476927, "Detection of COVID-19 Subjects Using DiaNose Exhalation Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04476927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*